The news in simple language from 01.09.2026 is about the start of training for young people, a ban on alcohol consumption at German train stations, a new weight loss pill, the verdict against a former gang leader in the Tupac murder case, and Lionel Messi's resignation from the Argentine national team. (translated)
For the first time in Germany, a GLP-1 medication for weight reduction will be available in the form of tablets in pharmacies starting September 1, 2026, after the EU granted approval. (translated)
In Germany, a new weight loss medication in tablet form containing the active ingredient Semaglutide will be available for the first time starting September 1, 2026, which is approved for weight reduction in individuals with obesity or overweight, although it will only be available by prescription and the costs will initially have to be borne by the patients themselves. (translated)
A new type of weight loss tablet containing the active substance Semaglutide will soon be available in Austria, which has a similar effect to the already approved injection, but requires a higher active ingredient content and is primarily intended for people with overweight or obesity, while its use, side effects, and potential risks should be considered under medical supervision. (translated)
Die EU hat die neue Gewichtsreduktions-Tablette Wegovy zugelassen, die den Wirkstoff von Ozempic enthält, und eine US-Nutzerin berichtet von ihren Erfahrungen mit dem Medikament, dessen Verfügbarkeit in Deutschland jedoch noch unklar ist. #Wegovy #Gewichtsreduktion #Abnehmtablette
